Introduction 29
Speech and language disorders affect millions of children worldwide 1 . These disorders are associated 30 with a number of pathologies, including autism spectrum 2 and attention deficit hyperactivity 31 disorders 3 , but they also occur in otherwise normally developing children. The causes of speech and 32 language disorders are poorly understood, but abnormal brain structure likely plays a crucial role 4 . 33 Interestingly, neither mice, the most common animal model for pre-clinical studies, nor our closest 34 relatives, non-human primates, share the human ability to learn vocalizations by imitating a 35 conspecific 5 . Songbirds, on the other hand, are gifted vocal learners and display many parallels with 36 speech acquisition in humans 6 . Therefore, songbirds provide an excellent model system to examine 37 the neural circuits associated with speech development. Songbird circuit research remains, however, 38 limited by the current lack of transgenic animal lines and proper neurogenetic tools. 39
The virally mediated delivery of genetic cargo to a specific neuron population is a highly valuable 40 approach for probing anatomy and circuit function. By entering at axon terminals, retrograde viral 41 vectors can specifically transduce projection neuron populations and provide direct access to the 42 wiring and function of the brain 7,8 . Unfortunately, viral vectors are not easily transferable between 43 model species. For example, rabies and canine adenovirus (CAV), the most commonly used 44 retrograde vectors in rodents, have never been shown to successfully infect avian tissue. Other 45 examples include adeno associated viral (AAV) vectors that are commonly used in rodents and other 46 mammals, but suffer from major limitations in accessing songbird projection neurons [9] [10] [11] [12] [13] [14] [15] . 47
The limitations of the AAV vectors so far applied for retrograde access to songbird projection neurons 48 are four-fold. First, these AAV vectors result in low transduction success rates, with only 18% to 43% 49 of intracerebral injections resulting in successful transgene expression 9 . Second, their transduction of 50 projection neurons is sparse, resulting in transgene expression in small portions of the targeted 51 populations 9,11 . This limitation makes these tools incompatible with studies requiring genetic 52 manipulations of a majority of neurons among a given type. The third limitation is weak transgene 53 expression 9,13 . For example, when used to induce fluorescent protein expression, the resulting limited 54 dendritic and axonal labeling 9,13 makes current retrograde tools unsuitable for morphological studies. 55
Finally, the fourth limitation of the current AAV vectors is that they require long incubation periods 56 of at least 4 to 6 weeks (and up to 6 months) post-injection until transgene expression becomes 57 detectable 10, 11, 13 . Such long incubation periods typically hinder any vocal development studies in 58 zebra finches (Taeniopygia guttata), the most common songbird model species in neuroscience. This 59 is because zebra finches undergo short song learning phases during the critical period for vocal 60 learning. This period ends 90 days after hatching and is accompanied by fast brain rewiring 16 . The 61 rapid succession of vocal learning events in songbirds thus requires fast viral tools for circuit 62 investigations. To date, no viral vector has proven to efficiently target projection neurons of the 63 songbird brain resulting in robust transgene expression in a relevant time frame. 64
Here we present a fast and reliable retrograde viral tool for the songbird brain. Briefly, we combined 65 a self-complementary (sc) plasmid organization of a capsid variant of AAV-DJ, AAV-DJ/9 17 , and an 66 expression cassette under the transcriptional control of the human cytomegalovirus (hCMV) 67 promoter/immediate-early enhancer (IE) in combination with a chimeric intron (chI), resulting in 68 AAV vectors according to scAAV-2-DJ/9-hCMV-I/E-chI-transgene-p(A) ( Fig. 1a,b ; Methods). In 69 several songbird species and in mice, we found that our viral construct is efficient in retrogradely 70 transducing projection neuron circuits within about one week after vector injection ( Fig. 1c 
Fast and efficient retrograde transduction of songbird projection neurons 82
First, we examined the transgene expression kinetics and stability of our viral construct. We assessed 83 expression performance in the corticostriatal connection from nucleus HVC (proper name) to Area 84 X. HVC, the songbird vocal premotor cortex analog, is a major hub during vocal learning, integrating 85 information from auditory 18 , dopaminergic 15 , and premotor 19 afferents. HVC includes three major 86 neuron populations: local interneurons, HVCRA neurons that project to the robust nucleus of the 87 arcopallium (RA), which innervates vocal and respiratory motor neurons, and HVCX neurons that 88 project to Area X, the basal ganglia part of a cortico-basal ganglia-thalamic loop involved in song 89 learning 20 . HVCX neurons are analogous to mammalian corticostriatal projection neurons, which are 90 involved in motor learning in mammals 21 . 91 hinting at a strikingly high transduction efficiency. Longer eGFP expression times of 14 and 28 days 120 did not further increase eGFP labeling densities (25.28 x 10 3 and 23.66 x 10 3 somata/mm 3 respectively, 121 n=8 hemispheres per time point; Fig. 2e ,g,j). These results suggest that the peak of native fluorescence 122 of eGFP expression is reached already 7 days post-delivery and that there is no obvious decay of 123 fluorescence or neurotoxicity for at least 4 weeks after injection. 124
Transduction success rate and specificity of retrograde projection-neuron labeling in songbirds 137
We assessed the transduction success rate of our eGFP-construct, and found consistent transduction 138 of HVCX neurons in 24 out of 24 single-injected hemispheres (n=12 birds) after a minimum of 7 days 139 after virus injection into Area X. For comparison, previous studies applying AAV vectors for 140 retrograde transduction in songbirds have reported overall successful transduction in as little as 18% 141 of virus injections (one brain pathway showing retrograde eGFP expression in 2 out of 11 injected 142 hemispheres) 9 . To date, we have not encountered a single injection of our eGFP-construct without 143 successful retrograde transduction of projection neurons after 7 days. 144
We further assessed the specificity of retrograde labeling. HVC and Area X are anatomically well 145 separated, which virtually excludes the possibility that viral particles passively diffuse from Area X 146 to HVC. In addition, the fact that this connection is unidirectional makes it safe to assume that all 147 labeled neurites in HVC belong to HVCX neurons. Nonetheless, some studies report the possibility 148 of trans-synaptic spread of AAV vectors 23,24 . To assess whether all labeled neurons are indeed HVCX 149 neurons, and to exclude any potential mislabeling, we examined the morphological characteristics of 150 eGFP-labeled HVC neurons. 151
The three main HVC neuron classes are morphologically well described and can be separated based 152 on dendritic spine densities 25 . HVC interneurons are mainly aspiny, HVCRA projection neurons are 153 moderately spiny (0.21 ± 0.07 spines/µm), and HVCX neurons have the highest dendritic spine 154 densities (0.70 ± 0.13 spines/µm). We analyzed 17 randomly chosen dendritic branches of various 155 lengths (total branch length of 396 µm) across n=4 adult male zebra finches (>7 days after injection). 156 A subset of histological brain sections was further subjected to anti-GFP immunolabeling to capture 157 any potentially low-transgene expressing cells. Analyzed dendritic branch fragments had dendritic 158 spine densities ranging from 0.47 to 1.75 spines/µm (average 1.03 ± 0.35 spines/µm, which compares 159 favorably with the previously reported 0.70 ± 0.13 spines/µm 25 ), indicating that eGFP-expressing 160 cells are most likely all HVCX neurons. Albeit some overlap in spine density between X-and RA-161 projecting cells, we did not encounter a single cell that was obviously either aspiny (interneuron) or 162 had a very low spine density (HVCRA neurons). 163
To further exclude the possibility of unspecific transduction of non-neuronal cell types such as 164 astrocytes, we performed anti-neuronal protein HuC/HuD counterstains, a common neuronal marker. 165
We found that all examined eGFP-labeled cells were also labeled with HuC/HuD antibody (n=4 166 sections), confirming their neuronal identity ( Fig. 3) . 
Visualization of morphological details in retrogradely labeled projection neurons 175
The weak transgene expression produced by previous retrograde vectors for songbirds typically 176 results in fluorescent protein-labeling that is often limited to somata and small extensions of proximal 177 neurites 9,13 . Using our new eGFP-construct thus opens new possibilities for highly detailed 178 morphological analysis of songbird projection neurons. In fact, the high expression levels of eGFP in 179 HVCX neurons 7 days post-delivery allowed a remarkable visualization of dendritic morphological 180 details. Adjacent to imaged dendrites, we found clearly distinguishable dendritic spines throughout 181 HVC ( Fig. 1e ), at sufficient detail to distinguish and trace different spine types ( Fig. 4) . 182
The extensive eGFP labeling makes our construct a promising candidate for in vivo imaging of 183 morphological plasticity. To date, in vivo imaging of dendritic spine plasticity in songbirds has been 184 achieved exclusively via lentivirus-mediated fluorescence labeling 12,26 , a tool that lacks retrograde 185 transduction capabilities. Furthermore, the strong eGFP expression we demonstrate is highly 186 beneficial for tissue processing techniques that require a strong initial fluorophore expression, 187
including large-volume expansion (lattice) light-sheet microscopy (ExLSM 27 , ExLLSM 28 ) and 188 whole-brain tissue clearing 29 . 189 In birds injected with our construct into Area X, we observed good retrograde eGFP labeling of 207 VTA/SNcX neurons. To identify the types of the labeled neurons, we immunolabeled histological 208 sections for tyrosine hydroxylase (TH), which is a good marker for dopamine and has been shown to 209 label the majority of VTA/SNcX neurons (estimates ranging from 88 to 95% of VTA/SNcX 210 neurons) 11,14,33 . We found that the majority of examined VTA/SNcX neurons were indeed positively 211 labeled for TH (n=4 birds, Fig. 1h-k ), suggesting that these neurons are dopaminergic. 212
The strength of retrograde labeling of dopaminergic VTA/SNc projection neurons in zebra finches 213 led us to investigate whether high labeling efficiency can also be observed in rodents. One of the most 214 effective retrograde vectors in rodents, AAV-retro, only poorly transduces mouse dopaminergic 215 projection neurons in the SNc 34 . Coincidently, we tested AAV-retro and found this construct to also 216 be non-functional in zebra finches (n=4 adult male zebra finches, single injections into Area X in both 217 hemispheres of the construct scAAV-2-retro-hCMV-I/E-chI-eGFP-p(A), with post-delivery incubation times of 6 weeks). When we injected our eGFP-construct into the striatum of mice, a major 219 projection target of the SNc, we found successful labeling of dopaminergic SNc projection neurons 220 (confirmed with TH-immunolabeling, n=5 mice, Fig. 1l-o) . vectors in the canary brain has been limited to the use of lentiviruses 37 , which do not retrogradely 231 transduce projection neurons. Injections of our eGFP-construct into canary Area X resulted in strong 232 eGFP expression in HVCX neurons 7 days after injection, confirming the rapid expression times 233 observed in zebra finches ( Fig. 1f,g) . 234
235
Brainbow labeling of projection neuron target circuits 236
One common problem associated with studying the structure of local neural circuits is excessive 237 labeling density, which can hinder the visual separation of adjacent neurons and their respective 238 dendrites. One tool that can potentially overcome this problem is brainbow labeling 38 . Brainbow 239 labeling color-codes neurons via the relative expression ratios of diverse fluorescent proteins. One 240 brainbow technique achieves diverse labeling colors via the selective uptake ratios of diverse viral 241 particle types. This technique involves simply mixing and co-injecting three individual vector types encoding different chemical tags or fluorophores 39 (Fig. 5a ). Brainbow labeling in any of its variants 243
has not yet been applied in songbirds. 244
In addition to the eGFP-expressing vector, we produced two additional vectors expressing spectrally 245 distinct fluorescent proteins, enhanced cyan fluorescent protein (eCFP) and red fluorescent protein 246 (mRuby3). Next, we injected the three aforementioned constructs in a ratio of 1:1:1 into Area X of 247 adult male zebra finches. Local expression within Area X produced spectrally diverse neuron labeling 248 ( Fig. 5b ) with consistent and dense fluorophore expression patterns throughout neurons including 249 morphological fine structures such as spines (Fig. 5c ). Although abundant brainbow labeling 250 strategies exist for mice, we are not aware of any AAV-based retrograde labeling strategy which does 251 not involve Cre-Lox recombination. We injected our eGFP-, eCFP-, and mRuby3-constructs in a ratio 252 of 1:1:1 into the murine area CA1 of the dorsal hippocampus (n=4). The injection of these three 253 constructs produced spectrally diverse labeling of projection neurons in the mouse entorhinal cortex 254 ( Fig. 5d) . 
Retrograde expression of calcium sensors 270
In light of the obvious benefits of our construct for visualization of projection neuron circuits, we 271 sought to investigate whether the expression of other genetic cargo could be mediated equally well. 272
The packaging capacity of natural AAV serotypes is limited to a genome size of about 4.7 kb. 273 Nevertheless, the absolute packaging limit of AAV vectors has been challenged and one recent study 274 found a brick-wall limit of 5.2 kb for AAV-8 40 . Because the maximum packaging size of an AAV 275 likely also depends on the exact protein composition of the nucleocapsid, we decided to produce the 276 same viral construct for GCaMP6f, with a total genome size of 5.286 kb, which is just over the 277 reported maximum. Production was successful and yielded a physical viral titer of 5.9 x 10 12 vg/ml, 278
which seemed promising to test for in vivo calcium imaging. 279
GCaMP is a genetically encoded calcium (Ca 2+ ) sensor 41 consisting of a circular GFP, calmodulin 280 (CaM) and a peptide chain (M13), which in its natural conformation shows only poor fluorescence. 281
In the presence of Ca 2+ , CaM undergoes a structural change that entails a rapid increase in 282 fluorescence. GCaMP6f was engineered for fast fluorescence dynamics and high Ca 2+ sensitivity, 283 resulting in reliable single-spike detection at 50-75 ms inter-spike intervals 42 . 284
We injected our GCaMP6f-construct into the RA of Bengalese finches (Lonchura striata var. 285 domestica), a further songbird species commonly used in birdsong research. We used a custom-built 286 miniaturized fluorescence microscope (see Methods) to image neuronal activity in vivo under 287 isoflurane anesthesia. We imaged spontaneous activity in HVCRA neurons (Fig. 6, Supplementary  288 Video 1), an HVC projection neuron population that generates precise temporal sequences 43 during 289 song production. In a field of view of (262.5 µm) 2 , we were able to detect 48 spiking events in 8 290 We present a new viral construct for retrograde delivery of genetic cargo to projection neuron circuits 316 in songbirds, with fast and robust transgene expression and high transduction efficiency. Our 317 construct, scAAV-2-DJ/9-hCMV-I/E-chI-transgene-p(A), is suitable for studying the detailed 318 connectivity and function of songbird corticostriatal and vocal motor pathways essential for vocal 319 learning. Our construct also provides reliable access to probe the structure of cortical and 320 dopaminergic projection neuron circuits in both songbirds and mice. These findings indicate the 321 applicability of our new vector in both species and circuits that appear to be resistant to retrograde 322 targeting with AAV vectors. 323
The current lack of reliable tools to target specific neuron populations in songbirds has been a possible 324 contributor to the underrepresentation of songbirds as model species in medical and applied research. 325
For targeted manipulations of projection neuron populations in the zebra finch, one serotype, AAV-9, 326 has previously been used 9-11,13 . However, these vectors entail significant drawbacks, such as low 327 transduction success rates, prolonged incubations times, and sparse and weak transgene expression, 328 all of which limit their application. These limitations were not remedied by the use of the presumably 329 stronger-expressing self-complementary variant of AAV-9 9,13 , nor by exploiting the cre-flex system 330 with the cre-recombinase vector injected at the projection target 10,11,13 . Unlike in songbirds, in mice, 331 the cre-flex system is very efficient and extremely low levels of cre are able to drive expression of 332 otherwise silenced transcripts 44 . 333
Despite previous limitations as retrograde tools for the songbird brain, AAV vectors still seemed 334 worth exploration thanks to their extensive capsid variety, with more than 100 existing capsid variants. 335
The inability of certain viral vectors to infect songbird tissue is likely owed to diverse factors. Such 336 factors possibly include incompatibility of co-receptors for cellular access of the viral vector, as well 337 as differences in promoter sequences and intracellular physiology, both of which can impair 338 transduction. A further potential limiting factor is a substantially different immune response in birds 339 compared to mammals. Commonly, immune defense systems pose the first barrier when exploring viral tools. Accordingly, the low transduction success rate of AAV-9 vectors hints towards a possible 341 strong immune response in zebra finches against this serotype. This hypothesis led us to explore 342 serotypes focusing on low immune response, which is a trait of vectors engineered for human gene 343 therapy. Human gene therapy vectors are required to have high transduction efficiency and low 344 immunogenicity, both of which were highly desirable characteristics for the new songbird viral tool 345 we were pursuing. 346 AAV serotypes have previously been selected in order to yield high efficiency and low 347 immunogenicity 17 . The single prevailing capsid, the AAV2, 8 & 9 chimera termed AAV-DJ, showed 348 superior transduction characteristics, which motivated us to test this capsid. We found that the 349 self-complementary variant of AAV-DJ shows great local expression in songbird brain tissue, with 350 great transduction characteristics, but unfortunately shows no retrograde transduction. Although 351
showing some potential for retrograde access to projection neurons 34,45,46 , AAV vectors are 352 traditionally not used for retrograde studies. One notable exception, the AAV-retro construct, has 353 demonstrated a 10-fold higher retrograde transduction efficiency than AAV-DJ 34 . This motivated us 354 to test AAV-retro, but we found this construct to be non-functional in zebra finches. We thus carefully 355 examined the changes introduced in AAV-retro, which presumably led to increased efficacy of 356 retrograde access. The critical changes appear to interact with the heparin sulfate proteoglycans 357 (HSPG) binding domain (HBD) 47 . The 10-mer insert between positions 587 and 588 ( Fig. 1a ) 358
probably both disrupts HBD's functionality, as demonstrated by the reduced heparin binding affinity 359 of AAV-retro, and creates a new binding surface, which might improve vesicular trafficking or nuclear 360 entry of viral particles 34 . Interestingly, the characteristics of the HBD were also carefully examined 361 by the creators of the AAV-DJ construct 17 . One of their negative controls produced for comparison to 362 AAV-DJ, AAV-DJ/9, included two point mutations in the HBD that disrupt heparin binding. These 363 two point mutations seemed to reduce transduction efficiency of AAV-DJ/9 in comparison to AAV-364 DJ, but surprisingly also induced faster transduction kinetics. Faster transduction kinetics was a 365 highly desirable characteristic for the new songbird viral tool we were pursuing, which peaked our 366 interest in the AAV-DJ/9 capsid variant. Coincidentally, the point mutations of the HBD in AAV-DJ/9 367 also rendered this serotype closer to its parental serotype AAV-9 17 (Fig. 1a) , which has been shown 368 to have some potential for retrograde access in songbirds [10] [11] [12] 14 . 369
The exact composition of our construct combines many features that most likely all contribute 370 constitutively to the highly efficient transgene expression and retrograde transport (Fig. 1a,b) . Clearly, 371 the AAV-DJ/9 capsid structure of the HBD plays a major role for the viral access through axon 372 terminals and the fast transduction kinetics. Nonetheless, this feature alone does not guarantee strong 373 retrograde expression. The viral vector also needs to be transported by the transduced cells lysosomal 374 system into the nucleus, where the genetic cargo has to be translated into messenger RNA (mRNA). 375
The process of conversion into mRNA in the nucleus can be drastically accelerated by packaging two 376 complementary copies of single stranded DNA genomes in a self-complementary AAV vector instead 377 of single stranded DNA genomes. However, self-complementary AAV vectors have also been shown 378 to induce a stronger immune response 48 . When applying a self-complementary AAV9-based vector 379 (scAAV9) for retrograde access in songbirds, the self-complementary genome seems to neither have 380 improved transduction success rates, transduction efficiency, nor expression kinetics 9 . The 381 disappointing results obtained with scAAV9 might, however, be partially explained by the chosen 382 promoter. Although a wide range of promoters have been applied to songbird brain tissue, we are not 383 aware of a promoter that stands out in projection neurons. The scAAV9 vector has been employed in 384 songbirds using a CBh promoter 9 , a hybrid variant of the chicken beta actin (CBa) promoter. 385
Nonetheless, CBh supposedly ensures strong expression through self-complementary vector 386 mediated transduction in neuron types that are also affected by CMV promoters 49 . Given the poor 387 transduction efficiency of scAAV-9-CBh, it could be that the hCMV immediate-early enhancer 388 (hCMV-I/E) and/or the chimeric intron (chI) of our self-complementary construct play crucial roles 389 for retrograde transduction in projection neurons. The introduced intron might contribute to the 390 improved transduction efficiency by regulating splicing of mRNA within the nucleus, which has been 391 shown to improve nuclear export 50 . Further investigations would be necessary to fully elucidate the 392 exact contributions of individual components to retrograde transport and transduction efficiency and 393
kinetics. 394
In this work we present a new viral construct for excellent access to specific projection neuron 395 populations in songbirds. We demonstrated the suitability of our new construct for in vivo imaging of 396 calcium activity (Fig. 6) , and for detailed morphological analysis based on extensive axonal and 397 dendritic labeling, using both single ( Fig. 4) and multi-color approaches (Fig. 5) . The high 398 transduction success rates and great transduction efficiency hint at the potential for this tool to make 
Design of self-complementary adeno-associated virus vector plasmids 558
Self-complementary adeno-associated virus (AAV) vector plasmids (pscAAV) were constructed as 559 previously described 1,2 . Briefly, the terminal resolution site (trs) and the packaging signal 560 (D-sequence) from psub-2-CBA-WPRE 3,4 were deleted by Bal I restriction digestion within the AAV 561 serotype 2 (AAV-2) 5' inverted terminal repeat (5'-ITR) resulting in the plasmid pscAAV-2-3'-ITR. 562 Subsequently, the multiple cloning site (MCS) of pBluescript II SK (+) (Stratagene) together with the 563 AAV-2 3'-ITR and simian virus 40 late polyadenylation signal (SV40p(A)) containing fragment of 564 psub-2-CMV-WPRE 3 were inserted into pscAAV-2-3'-ITR, resulting in the plasmid pscAAV-2-565 MCS-SV40p(A). In the AAV vector plasmids used here (Fig. 1b The eGFP open reading frame (ORF) was amplified by PCR using pscAAV-2-hCMV-chI-floxedeGFP 570 as the template DNA and primers 5'-ATACTAGTGCCACCATGGTGAGCAAGGGCG-3' (forward) 571 and 5'-TTGCGCGGCCGCTTACTTGTACAGCTCGTCCATG3' (reverse). Amplicons were Spe 572 I/Not I restriction digested and inserted into the Spe I/Not I restriction digested 573 pscAAV-2-hCMV-chI-floxedeGFP to generate pscAAV-2-hCMV-chI-eGFP (eGFP vector plasmid). 574
For construction of the mRuby3 vector plasmid (pscAAV-2-hCMV-chI-mRuby3-SV40p(A)), the 575 mRuby3 ORF was amplified by PCR using Addgene #85146 as the template DNA and primers 576 5'-CATTACTAGTGTTTAAACACTCGAGGCTAGCGCCACCATGGTGTCTAAGG-3' (forward) 577 and 5'-TAGGCGCGCCTACGTACAATTGGGTACCTTACTTGTACAGCTCGTCCATG-3' 578 (reverse). The resulting PCR product was cut with SpeI and BsrGI and inserted into the Spe I and 579
BsrG I sites of the eGFP vector plasmid. 580
For construction of the eCFP vector plasmid (pscAAV-2-hCMV-chI-eCFP-SV40p(A)), the eCFP 581 ORF was isolated from plasmid pBV1 as Nhe I/Sac II fragment and inserted into the Sac II/Spe I 582 opened eGFP vector plasmid. 583
For construction of the GCaMP6f vector plasmid (pscAAV-2-hCMV-chI-GCaMP6f-SV40p(A)), the 584
GCaMP6f ORF  was  isolated  by  Bgl  II/BstB  I  restriction  digest  from  585 pssAAV-2-hSyn1-chI-GCaMP6f-WPRE-SV40p(A) (N-terminal part of GCaMP6f) and by BstB 586
